Rodent models for investigating the dysregulation of immune responses in type 1 diabetes

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Chou, Feng Cheng ^a   Chen, Heng Yi ^a   Chen, Shyi Jou ^b   Fang, Mei Cho ^a   Sytwu, Huey Kang ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 35; INTERLEUKIN 4; REACTIVE OXYGEN METABOLITE; SUPPRESSOR OF CYTOKINE SIGNALING 1; T LYMPHOCYTE RECEPTOR; THIOREDOXIN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; AUTOIMMUNITY; CELL DESTRUCTION; CELL FUNCTION; GENE CONTROL; GENE OVEREXPRESSION; GENETIC MANIPULATION; IMMUNE DYSREGULATION; IMMUNOCOMPETENT CELL; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT GENE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW; T CELL DEPLETION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 84879396457     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/138412     Document Type: Review

References (77)

1. Gillespie K. M., Type 1 diabetes: pathogenesis and prevention. Canadian Medical Association Journal 2006 175 2 165 170 2-s2.0-33746207753 10.1503/cmaj.060244 (Pubitemid 44126252)
2. Karvonen M., Viik-Kajander M., Moltchanova E., Libman I., LaPorte R., Tuomilehto J., Incidence of childhood type 1 diabetes worldwide. Diabetes Care 2000 23 10 1516 1526 2-s2.0-0033808399
3. EURODIAB ACE Study Group, Variation and trends in incidence of childhood diabetes in Europe. The Lancet 2000 355 9207 873 876 2-s2.0-0034635768 10.1016/S0140-6736(99)07125-1 (Pubitemid 30137666)
4. Harjutsalo V., Sjöberg L., Tuomilehto J., Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. The Lancet 2008 371 9626 1777 1782 2-s2.0-43849096855 10.1016/S0140-6736(08)60765-5 (Pubitemid 351697953)
5. Mordes J. P., Bortell R., Doukas J., Rigby M., Whalen B., Zipris D., Greiner D. L., Rossini A. A., The BB/Wor rat and the balance hypothesis of autoimmunity. Diabetes/Metabolism Reviews 1996 12 2 103 109 2-s2.0-0029760157 (Pubitemid 26280009)
6. Komeda K., Noda M., Terao K., Kuzuya N., Kanazawa M., Kanazawa Y., Establishment of two substrains, diabetes-prone and non-diabetic, from Long-Evans Tokushima Lean (LETL) rats. Endocrine Journal 1998 45 6 737 744 2-s2.0-0032469294 (Pubitemid 29082595)
7. Lenzen S., Tiedge M., Elsner M., Lortz S., Weiss H., Jörns A., Klöppel G., Wedekind D., Prokop C. M., Hedrich H. J., The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus. Diabetologia 2001 44 9 1189 1196 2-s2.0-17944372927 10.1007/s001250100625 (Pubitemid 32835513)
8. Ellerman K. E., Like A. A., Susceptibility to diabetes is widely distributed in normal class II(u) haplotype rats. Diabetologia 2000 43 7 890 898 2-s2.0-0033941714 (Pubitemid 30463169)
9. Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., Tochino Y., Breeding of a non-obese, diabetic strain of mice. Experimental Animals 1980 29 1 1 13 2-s2.0-0018841766 (Pubitemid 10185796)
10. Anderson M. S., Bluestone J. A., The NOD mouse: a model of immune dysregulation. Annual Review of Immunology 2005 23 447 485 2-s2.0-17644361955 10.1146/annurev.immunol.23.021704.115643 (Pubitemid 40563177)
11. Tisch R., McDevitt H., Insulin-dependent diabetes mellitus. Cell 1996 85 3 291 297 2-s2.0-0029954214 10.1016/S0092-8674(00)81106-X (Pubitemid 26160699)
12. Hattori M., Buse J. B., Jackson R. A., Glimcher L., Dorf M. E., Minami M., Makino S., Moriwaki K., Kuzuya H., Imura H., The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 1986 231 4739 733 735 2-s2.0-0022646067 (Pubitemid 16104046)
13. Acha-Orbea H., McDevitt H. O., The first external domain of the nonobese diabetic mouse class II I-A β chain is unique. Proceedings of the National Academy of Sciences of the United States of America 1987 84 8 2435 2439 2-s2.0-0003403213 (Pubitemid 17075881)
14. Kanagawa O., Martin S. M., Vaupel B. A., Carrasco-Marin E., Unanue E. R., Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction. Proceedings of the National Academy of Sciences of the United States of America 1998 95 4 1721 1724 2-s2.0-0032539536
15. Jansen A., Homo-Delarche F., Hooijkaas H., Leenen P. J., Dardenne M., Drexhage H. A., Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and β -cell destruction in NOD mice. Diabetes 1994 43 5 667 675 2-s2.0-0028223127 (Pubitemid 24138780)
16. Delovitch T. L., Singh B., The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1997 7 6 727 738 2-s2.0-0031423760 10.1016/S1074-7613(00)80392-1 (Pubitemid 28064887)
17. Su X., Hu Q., Kristan J. M., Costa C., Shen Y., Gero D., Matis L. A., Wang Y., Significant role for Fas in the pathogenesis of autoimmune diabetes. Journal of Immunology 2000 164 5 2523 2532 2-s2.0-0034162513 (Pubitemid 30115482)
18. Silva D. G., Petrovsky N., Socha L., Slattery R., Gatenby P., Charlton B., Mechanisms of accelerated immune-mediated diabetes resulting from islet β cell expression of a Fas ligand transgene. Journal of Immunology 2003 170 10 4996 5002 2-s2.0-0037988807 (Pubitemid 36554729)
19. Chervonsky A. V., Wang Y., Wong F. S., Visintin I., Flavell R. A., Janeway C. A. Jr., Matis L. A., The role of Fas in autoimmune diabetes. Cell 1997 89 1 17 24 2-s2.0-0030890721 (Pubitemid 27180581)
20. Sung H. H., Juang J. H., Lin Y. C., Kuo C. H., Hung J. T., Chen A., Chang D. M., Chang S. Y., Hsieh S. L., Sytwu H. K., Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice. Journal of Experimental Medicine 2004 199 8 1143 1151 2-s2.0-2442536706 10.1084/jem.20031939 (Pubitemid 38619910)
21. Pitti R. M., Marsters S. A., Lawrence D. A., Roy M., Kischkel F. C., Dowd P., Huang A., Donahue C. J., Sherwood S. W., Baldwin D. T., Godowski P. J., Wood W. I., Gurney A. L., Hillan K. J., Cohen R. L., Goddard A. D., Botstein D., Ashkenazi A., Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998 396 6712 699 703 2-s2.0-17444424930 10.1038/25387 (Pubitemid 29003951)
22. Gao W., Demirci G., Li X. C., Negative T cell costimulation and islet tolerance. Diabetes/Metabolism Research and Reviews 2003 19 3 179 185 2-s2.0-0037604843 10.1002/dmrr.345 (Pubitemid 36675957)
23. Wang C. J., Chou F. C., Chu C. H., Wu J. C., Lin S. H., Chang D. M., Sytwu H. K., Protective role of programmed death 1 ligand 1 (PD-L1) in nonobese diabetic mice: the paradox in transgenic models. Diabetes 2008 57 7 1861 1869 2-s2.0-48249141150 10.2337/db07-1260
24. Shieh S. J., Chou F. C., Yu P. N., Lin W. C., Chang D. M., Roffler S. R., Sytwu H. K., Transgenic expression of single-chain anti-CTLA-4 Fv on β cells protects nonobese diabetic mice from autoimmune diabetes. Journal of Immunology 2009 183 4 2277 2285 2-s2.0-70149123492 10.4049/jimmunol.0900679
25. Subudhi S. K., Zhou P., Yerian L. M., Chin R. K., Lo J. C., Anders R. A., Sun Y., Chen L., Wang Y., Alegre M. L., Fu Y. X., Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. Journal of Clinical Investigation 2004 113 5 694 700 2-s2.0-11144358197 10.1172/JCI200419210 (Pubitemid 38544162)
26. Yantha J., Tsui H., Winer S., Song A., Wu P., Paltser G., Ellis J., Dosch H. M., Unexpected acceleration of type 1 diabetes by transgenic expression of B7-H1 in NOD mouse peri-islet glia. Diabetes 2010 59 10 2588 2596 2-s2.0-77957580490 10.2337/db09-1209
27. Wong S., Guerder S., Visintin I., Reich E. P., Swenson K. E., Flavell R. A., Janeway C. A. Jr., Expression of the co-stimulator molecule B7-1 in pancreatic β -cells accelerates diabetes in the NOD mouse. Diabetes 1995 44 3 326 329 2-s2.0-0028921986
28. Sytwu H. K., Lin W. D., Roffler S. R., Hung J. T., Sung H. S., Wang C. H., Cheng T. L., Tsou S. C., Hsi S. C., Shen K. L., Anti-4-1BB-based immunotherapy for autoimmune diabetes: lessons from a transgenic non-obese diabetic (NOD) model. Journal of Autoimmunity 2003 21 3 247 254 2-s2.0-10744220063 10.1016/S0896-8411(03)00112-4 (Pubitemid 37410112)
29. Mueller R., Krahl T., Sarvetnick N., Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. Journal of Experimental Medicine 1996 184 3 1093 1099 2-s2.0-0029838995 (Pubitemid 26313566)
30. Grewal I. S., Grewal K. D., Wong F. S., Wang H., Picarella D. E., Janeway C. A. Jr., Flavell R. A., Expression of transgene encoded TGF- β in islets prevents autoimmune diabetes in NOD mice by a local mechanism. Journal of Autoimmunity 2002 19 1-2 9 22 2-s2.0-0036700341 10.1006/jaut.2002.0599 (Pubitemid 35205196)
31. Moritani M., Yoshimoto K., Wong S. F., Tanaka C., Yamaoka T., Sano T., Komagata Y., Miyazaki J. I., Kikutani H., Itakura M., Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF- β 1. Journal of Clinical Investigation 1998 102 3 499 506 2-s2.0-18544392433 (Pubitemid 28376152)
32. Wogensen L., Lee M. S., Sarvetnick N., Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. Journal of Experimental Medicine 1994 179 4 1379 1384 2-s2.0-0028346888 (Pubitemid 24091799)
33. Stephens L. A., Kay T. W. H., Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse. International Immunology 1995 7 12 1885 1895 2-s2.0-0029558631 (Pubitemid 26003695)
34. Zheng X. X., Steele A. W., Hancock W. W., Stevens A. C., Nickerson P. W., Roy-Chaudhury P., Tian Y., Strom T. B., A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. Journal of Immunology 1997 158 9 4507 4513 2-s2.0-0031131886 (Pubitemid 127483957)
35. Pennline K. J., Roque-Gaffney E. R., Monahan M., Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clinical Immunology and Immunopathology 1994 71 2 169 175 2-s2.0-0028222756 10.1006/clin.1994.1068 (Pubitemid 24147233)
36. Collison L. W., Workman C. J., Kuo T. T., Boyd K., Wang Y., Vignali K. M., Cross R., Sehy D., Blumberg R. S., Vignali D. A., The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007 450 7169 566 569 10.1038/nature06306 (Pubitemid 350190247)
37. Bettini M., Castellaw A. H., Lennon G. P., Burton A. R., Vignali D. A., Prevention of autoimmune diabetes by ectopic pancreatic β -cell expression of interleukin-35. Diabetes 2012 61 6 1519 1526 10.2337/db11-0784
38. Martin A. P., Grisotto M. G., Canasto-Chibuque C., Kunkel S. L., Bromberg J. S., Furtado G. C., Lira S. A., Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice. Diabetes 2008 57 2 387 394 2-s2.0-40749154028 10.2337/db07-1309
39. Lin G. J., Huang S. H., Chen Y. W., Hueng D. Y., Chia W. T., Chien M. W., Yen B. L., Sytwu H. K., Transgenic expression of murine chemokine decoy receptor D6 by islets reveals the role of inflammatory CC chemokines in the development of autoimmune diabetes in NOD mice. Diabetologia 2011 54 7 1777 1787 10.1007/s00125-011-2166-9
40. + T lymphocytes. Journal of Clinical Investigation 2000 105 4 459 468 2-s2.0-0033621893 (Pubitemid 30127246)
41. Flodström-Tullberg M., Yadav D., Hägerkvist R., Tsai D., Secrest P., Stotland A., Sarvetnick N., Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse. Diabetes 2003 52 11 2696 2700 2-s2.0-0242268904 10.2337/diabetes.52.11.2696 (Pubitemid 37339699)
42. Lenzen S., Drinkgern J., Tiedge M., Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radical Biology and Medicine 1996 20 3 463 466 2-s2.0-0029984682 10.1016/0891-5849(96)02051-5 (Pubitemid 26077870)
43. Hotta M., Tashiro F., Ikegami H., Niwa H., Ogihara T., Yodoi J., Miyazaki J. I., Pancreatic β cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. Journal of Experimental Medicine 1998 188 8 1445 1451 2-s2.0-0032547768 10.1084/jem.188.8.1445 (Pubitemid 28489581)
44. Huang S. H., Chu C. H., Yu J. C., Chuang W. C., Lin G. J., Chen P. L., Chou F. C., Chau L. Y., Sytwu H. K., Transgenic expression of haem oxygenase-1 in pancreatic β cells protects non-obese mice used as a model of diabetes from autoimmune destruction and prolongs graft survival following islet transplantation. Diabetologia 2010 53 11 2389 2400 2-s2.0-77957653459 10.1007/s00125-010-1858-x
45. Chou F. C., Huang S. H., Sytwu H. K., Genetically engineered islets and alternative sources of insulin-producing cells for treating autoimmune diabetes: quo vadis? International Journal of Endocrinology 2012 2012 9 296485 10.1155/2012/296485
46. Delong T., Baker R. L., He J., Haskins K., Novel autoantigens for diabetogenic CD4 T cells in autoimmune diabetes. Immunologic Research 2013 55 1-3 167 172 10.1007/s12026-012-8375-6
47. Katz J. D., Wang B., Haskins K., Benoist C., Mathis D., Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993 74 6 1089 1100 2-s2.0-0027378612 10.1016/0092-8674(93)90730-E (Pubitemid 23289465)
48. + islet-antigen-specific T-cell clones. Journal of Autoimmunity 2004 22 2 107 109 2-s2.0-1342308440 10.1016/j.jaut.2003.10.006 (Pubitemid 38252967)
49. Schmidt D., Verdaguer J., Averill N., Santamaria P., A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. Journal of Experimental Medicine 1997 186 7 1059 1075 2-s2.0-0030779118 10.1084/jem.186.7.1059 (Pubitemid 27441150)
50. Pauza M. E., Dobbs C. M., He J., Patterson T., Wagner S., Anobile B. S., Bradley B. J., Lo D., Haskins K., T-cell receptor transgenic response to an endogenous polymorphic autoantigen determines susceptibility to diabetes. Diabetes 2004 53 4 978 988 2-s2.0-1842475452 10.2337/diabetes.53.4.978 (Pubitemid 38436610)
51. Verdaguer J., Schmidt D., Amrani A., Anderson B., Averill N., Santamaria P., Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. Journal of Experimental Medicine 1997 186 10 1663 1676 2-s2.0-0030724897 10.1084/jem.186.10.1663 (Pubitemid 27506280)
52. Bending D., de la Peña H., Veldhoen M., Phillips J. M., Uyttenhove C., Stockinger B., Cooke A., Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. Journal of Clinical Investigation 2009 119 3 565 572 2-s2.0-67650650890 10.1172/JCI37865
53. Martin-Orozco N., Chung Y., Chang S. H., Wang Y. H., Dong C., Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. European Journal of Immunology 2009 39 1 216 224 2-s2.0-60549086638 10.1002/eji.200838475
54. Poulin M., Haskins K., Induction of diabetes in nonobese diabetic mice by Th2 T cell clones from a TCR transgenic mouse. Journal of Immunology 2000 164 6 3072 3078 2-s2.0-0034653472 (Pubitemid 30148967)
55. Tian J., Lehmann P. V., Kaufman D. L., T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. Journal of Experimental Medicine 1994 180 5 1979 1984 2-s2.0-0028143519 10.1084/jem.180.5.1979 (Pubitemid 24328590)
56. Horwitz M. S., Bradley L. M., Harbertson J., Krahl T., Lee J., Sarvetnick N., Diabetes induced by coxsackie virus: initiation by bystander damage and not molecular mimicry. Nature Medicine 1998 4 7 781 785 2-s2.0-0031874342 10.1038/nm0798-781 (Pubitemid 28331018)
57. Filippi C. M., Estes E. A., Oldham J. E., von Herrath M. G., Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. Journal of Clinical Investigation 2009 119 6 1515 1523 2-s2.0-67650999438 10.1172/JCI38503
58. Tracy S., Drescher K. M., Jackson J. D., Kim K., Kono K., Enteroviruses, type 1 diabetes and hygiene: a complex relationship. Reviews in Medical Virology 2010 20 2 106 116 2-s2.0-77649168078 10.1002/rmv.639
59. Nejentsev S., Walker N., Riches D., Egholm M., Todd J. A., Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009 324 5925 387 389 2-s2.0-65249131713 10.1126/science. 1167728
60. Starr T. K., Jameson S. C., Hogquist K. A., Positive and negative selection of T cells. Annual Review of Immunology 2003 21 139 176 2-s2.0-0042470456 10.1146/annurev.immunol.21.120601.141107 (Pubitemid 37174529)
61. Wing K., Sakaguchi S., Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nature Immunology 2010 11 1 7 13 2-s2.0-74049164847 10.1038/ni.1818
62. Ohashi P. S., Oehen S., Buerki K., Pircher H., Ohashi C. T., Odermatt B., Malissen B., Zinkernagel R. M., Hengartner H., Ablation of " tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991 65 2 305 317 2-s2.0-0025755292 10.1016/0092-8674(91) 90164-T (Pubitemid 121006060)
63. Oldstone M. B. A., Nerenberg M., Southern P., Price J., Lewicki H., Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991 65 2 319 331 2-s2.0-0025754853 10.1016/0092-8674(91)90165-U (Pubitemid 121006061)
64. + T cells. European Journal of Immunology 1992 22 4 1013 1022 2-s2.0-0026571924
65. Degermann S., Reilly C., Scott B., Ogata L., von Boehmer H., Lo D., On the various manifestations of spontaneous autoimmune diabetes in rodent models. European Journal of Immunology 1994 24 12 3155 3160 2-s2.0-0028582150 10.1002/eji.1830241236
66. Dissanayake D., Gronski M. A., Lin A., Elford A. R., Ohashi P. S., Immunological perspective of self versus tumor antigens: insights from the RIP-gp model. Immunological Reviews 2011 241 1 164 179 2-s2.0-79954458103 10.1111/j.1600-065X.2011.01014.x
67. Wicker L. S., Todd J. A., Peterson L. B., Genetic control of autoimmune diabetes in the NOD mouse. Annual Review of Immunology 1995 13 179 200 2-s2.0-0028922437
68. Morahan G., Insights into type 1 diabetes provided by genetic analyses. Current Opinion in Endocrinology, Diabetes, and Obesity 2012 19 4 263 270
69. Devendra D., Liu E., Eisenbarth G. S., Type 1 diabetes: recent developments. The British Medical Journal 2004 328 7442 750 754 2-s2.0-1642443489 (Pubitemid 38406430)
70. Gregersen J. W., Holmes S., Fugger L., Humanized animal models for autoimmune diseases. Tissue Antigens 2004 63 5 383 394 2-s2.0-2442604214 10.1111/j.0001-2815.2004.00243.x (Pubitemid 38648205)
71. Herman A. E., Tisch R. M., Patel S. D., Parry S. L., Olson J., Noble J. A., Cope A. P., Cox B., Congia M., McDevitt H. O., Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif. Journal of Immunology 1999 163 11 6275 6282 2-s2.0-0033485917
72. Liu J., Purdy L. E., Rabinovitch S., Jevnikar A. M., Elliott J. F., Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA10301, DQB10302 transgenic IA(null) NOD mice. Diabetes 1999 48 3 469 477 2-s2.0-0033048174 (Pubitemid 29106858)
73. Di Lorenzo T. P., Peakman M., Roep B. O., Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clinical and Experimental Immunology 2007 148 1 1 16 2-s2.0-33847629171 10.1111/j.1365-2249.2006.03244.x (Pubitemid 46364983)
74. Wen L., Wong F. S., Tang J., Chen N. Y., Altieri M., David C., Flavell R., Sherwin R., In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. Journal of Experimental Medicine 2000 191 1 97 104 2-s2.0-0034598313 10.1084/jem.191.1.97 (Pubitemid 30043651)
75. Wen L., Chen N. Y., Tang J., Sherwin R., Wong F. S., The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. Journal of Clinical Investigation 2001 107 7 871 880 2-s2.0-0035061420 (Pubitemid 32274040)
76. von Herrath M., Nepom G. T., Animal models of human type 1 diabetes. Nature Immunology 2009 10 2 129 132 2-s2.0-58449085511 10.1038/ni0209-129
77. Polychronakos C., Li Q., Understanding type 1 diabetes through genetics: advances and prospects. Nature Reviews in Genetics 2011 12 11 781 792 10.1038/nrg3069